74 related articles for article (PubMed ID: 23188542)
1. Thyroidectomy Outcomes in Patients Identified With RET Pathogenic Variants Through a Population Genomic Screening Program.
Pichardo PFA; Hellums RN; Hao J; Savatt JM; Hassen D; Pellitteri PK; Alvi M; Buchanan AH; Purdy NC
JAMA Otolaryngol Head Neck Surg; 2023 Mar; 149(3):195-202. PubMed ID: 36602781
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib.
Kraft IL; Akshintala S; Zhu Y; Lei H; Derse-Anthony C; Dombi E; Steinberg SM; Lodish M; Waguespack SG; Kapustina O; Fox E; Balis FM; Merino MJ; Meltzer PS; Glod JW; Shern JF; Widemann BC
Clin Cancer Res; 2018 Feb; 24(4):753-765. PubMed ID: 29187393
[No Abstract] [Full Text] [Related]
3. Improved Adherence to ATA Medullary Thyroid Cancer Treatment Guidelines.
McMullin JL; Sharma J; Gillespie T; Patel SG; Weber CJ; Saunders ND
Ann Surg Oncol; 2023 Nov; 30(12):7165-7171. PubMed ID: 36367629
[TBL] [Abstract][Full Text] [Related]
4. RET gene abnormalities and thyroid disease: who should be screened and when.
Salehian B; Samoa R
J Clin Res Pediatr Endocrinol; 2013; 5 Suppl 1(Suppl 1):70-8. PubMed ID: 23455356
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium.
Machens A; Lorenz K; Sekulla C; Höppner W; Frank-Raue K; Raue F; Dralle H
Eur J Endocrinol; 2013 Mar; 168(3):307-14. PubMed ID: 23211574
[TBL] [Abstract][Full Text] [Related]
6. Two sisters diagnosed with familial paraganglioma syndrome type 1 (FPGL1) and multiple endocrine neoplasia type 2A (MEN2A).
Stawarz K; Durzynska M; Galazka A; Paszkowska M; Bienkowska-Pluta K; Zwolinski J; Tysarowski A; Kwiatkowska E; Podgorska A
World J Surg Oncol; 2024 May; 22(1):139. PubMed ID: 38802890
[TBL] [Abstract][Full Text] [Related]
7. Voltage-Gated Sodium Channel Na
Pukkanasut P; Whitt J; Guenter R; Lynch SE; Gallegos C; Rosendo-Pineda MJ; Gomora JC; Chen H; Lin D; Sorace A; Jaskula-Sztul R; Velu SE
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345144
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic and Early Thyroidectomy in
Torresan F; Censi S; Pennelli G; Galuppini F; Mian C; Iacobone M
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551711
[TBL] [Abstract][Full Text] [Related]
9. Cancer Genetic Counseling-Current Practice and Future Challenges.
Schienda J; Stopfer J
Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548230
[TBL] [Abstract][Full Text] [Related]
10. Bilateral Medullary Thyroid Carcinoma in a 3-Year-Old Female Patient with Multiple Endocrine Neoplasia 2A Syndrome Undergoing Prophylactic Thyroidectomy: Should Current Guidelines Be Revised?
Al-Kurd A; Gross DJ; Zangen D; Atlan K; Mazeh H; Grozinsky-Glasberg S
Eur Thyroid J; 2018 Oct; 7(5):267-271. PubMed ID: 30374431
[TBL] [Abstract][Full Text] [Related]
11. Notch3 as a novel therapeutic target in metastatic medullary thyroid cancer.
Lou I; Odorico S; Yu XM; Harrison A; Jaskula-Sztul R; Chen H
Surgery; 2018 Jan; 163(1):104-111. PubMed ID: 29128180
[TBL] [Abstract][Full Text] [Related]
12. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells.
Bertazza L; Barollo S; Radu CM; Cavedon E; Simioni P; Faggian D; Plebani M; Pelizzo MR; Rubin B; Boscaro M; Pezzani R; Mian C
J Cell Mol Med; 2015 Sep; 19(9):2244-52. PubMed ID: 26081844
[TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction.
Jaskula-Sztul R; Eide J; Tesfazghi S; Dammalapati A; Harrison AD; Yu XM; Scheinebeck C; Winston-McPherson G; Kupcho KR; Robers MB; Hundal AK; Tang W; Chen H
Mol Cancer Ther; 2015 Feb; 14(2):499-512. PubMed ID: 25512616
[TBL] [Abstract][Full Text] [Related]
15. Number of tumor foci predicts prognosis in papillary thyroid cancer.
Qu N; Zhang L; Ji QH; Zhu YX; Wang ZY; Shen Q; Wang Y; Li DS
BMC Cancer; 2014 Dec; 14():914. PubMed ID: 25471041
[TBL] [Abstract][Full Text] [Related]
16. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).
Niederle B; Sebag F; Brauckhoff M
Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502
[TBL] [Abstract][Full Text] [Related]
17. Current understanding and management of medullary thyroid cancer.
Roy M; Chen H; Sippel RS
Oncologist; 2013; 18(10):1093-100. PubMed ID: 24037980
[TBL] [Abstract][Full Text] [Related]
18. Hereditary medullary thyroid cancer: age-appropriate thyroidectomy improves disease-free survival.
Shepet K; Alhefdhi A; Lai N; Mazeh H; Sippel R; Chen H
Ann Surg Oncol; 2013 May; 20(5):1451-5. PubMed ID: 23188542
[TBL] [Abstract][Full Text] [Related]
19. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
Pelizzo MR; Torresan F; Boschin IM; Nacamulli D; Pennelli G; Barollo S; Rubello D; Mian C
Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
